PPAR-γ agonist protects against intestinal injury during necrotizing enterocolitis

Biochemical and Biophysical Research Communications

Volumn 379, Issue 2, 2009, Pages 423-427

  Baregamian, Naira ^a   Mourot, Joshua M ^a   Ballard, Amie R ^a   Evers, B Mark ^a,b   Chung, Dai H ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Ischemia reperfusion injury; Necrotizing enterocolitis; Nuclear factor kappaB; Peroxisome proliferator activated receptor

Indexed keywords

DELTA15 PROSTAGLANDIN J2; DRUG VEHICLE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER RECEPTOR HOMOLOG 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROSTAGLANDIN J2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE INJURY; MOUSE; NECROTIZING ENTEROCOLITIS; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY OBSTRUCTION;

ANIMALS; CELL LINE; ENTEROCOLITIS, NECROTIZING; HUMANS; INTESTINE, SMALL; MICE; MICE, INBRED STRAINS; NF-KAPPA B; PPAR GAMMA; PROSTAGLANDIN D2; REPERFUSION INJURY;

MUS;

EID: 58149488639     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.11.155     Document Type: Article

References (26)

1. Fanaroff A.A., Stoll B.J., Wright L.L., Carlo W.A., Ehrenkranz R.A., Stark A.R., Bauer C.R., Donovan E.F., Korones S.B., Laptook A.R., Lemons J.A., Oh W., Papile L.A., Shankaran S., Stevenson D.K., Tyson J.E., and Poole W.K. Trends in neonatal morbidity and mortality for very low birthweight infants. Am. J. Obstet. Gynecol. 196 (2007) 147 e1-8
2. Clark D.A., Fornabaio D.M., McNeill H., Mullane K.M., Caravella S.J., and Miller M.J. Contribution of oxygen-derived free radicals to experimental necrotizing enterocolitis. Am. J. Pathol. 130 (1988) 537-542
3. Kelly N., Friend K., Boyle P., Zhang X.R., Wong C., Hackam D.J., Zamora R., Ford H.R., and Upperman J.S. The role of the glutathione antioxidant system in gut barrier failure in a rodent model of experimental necrotizing enterocolitis. Surgery 136 (2004) 557-566
4. Chung D.H., Ethridge R.T., Kim S., Owens-Stovall S., Hernandez A., Kelly D.R., and Evers B.M. Molecular mechanisms contributing to necrotizing enterocolitis. Ann. Surg. 233 (2001) 835-842
5. Markel T.A., Crisostomo P.R., Wairiuko G.M., Pitcher J., Tsai B.M., and Meldrum D.R. Cytokines in necrotizing enterocolitis. Shock 25 (2006) 329-337
6. Halpern M.D., Clark J.A., Saunders T.A., Doelle S.M., Hosseini D.M., Stagner A.M., and Dvorak B. Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G757-G764
7. Mercurio F., and Manning A.M. NF-kappaB as a primary regulator of the stress response. Oncogene 18 (1999) 6163-6171
8. De Plaen I.G., Liu S.X., Tian R., Neequaye I., May M.J., Han X.B., Hsueh W., Jilling T., Lu J., and Caplan M.S. Inhibition of nuclear factor-kappaB ameliorates bowel injury and prolongs survival in a neonatal rat model of necrotizing enterocolitis. Pediatr. Res. 61 (2007) 716-721
9. Schoonjans K., Martin G., Staels B., and Auwerx J. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr. Opin. Lipidol. 8 (1997) 159-166
10. Jiang C., Ting A.T., and Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86
11. Ricote M., Li A.C., Willson T.M., Kelly C.J., and Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
12. Lafemina M.J., Sheldon R.A., and Ferriero D.M. Acute hypoxia-ischemia results in hydrogen peroxide accumulation in neonatal but not adult mouse brain. Pediatr. Res. 59 (2006) 680-683
13. Ponferrada A., Caso J.R., Alou L., Colon A., Sevillano D., Moro M.A., Lizasoain I., Menchen P., Gomez-Lus M.L., Lorenzo P., Cos E., Leza J.C., and Menchen L. The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction. Gastroenterology 132 (2007) 1791-1803
14. Rasbach K.A., and Schnellmann R.G. PGC-1alpha over-expression promotes recovery from mitochondrial dysfunction and cell injury. Biochem. Biophys. Res. Commun. 355 (2007) 734-739
15. Desreumaux P., Dubuquoy L., Nutten S., Peuchmaur M., Englaro W., Schoonjans K., Derijard B., Desvergne B., Wahli W., Chambon P., Leibowitz M.D., Colombel J.F., and Auwerx J. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J. Exp. Med. 193 (2001) 827-838
16. Combs C.K., Johnson D.E., Karlo J.C., Cannady S.B., and Landreth G.E. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J. Neurosci. 20 (2000) 558-567
17. Kawahito Y., Kondo M., Tsubouchi Y., Hashiramoto A., Bishop-Bailey D., Inoue K., Kohno M., Yamada R., Hla T., and Sano H. 15-Deoxy-delta(12, 14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J. Clin. Invest. 106 (2000) 189-197
18. Su C.G., Wen X., Bailey S.T., Jiang W., Rangwala S.M., Keilbaugh S.A., Flanigan A., Murthy S., Lazar M.A., and Wu G.D. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J. Clin. Invest. 104 (1999) 383-389
19. Nakajima A., Wada K., Miki H., Kubota N., Nakajima N., Terauchi Y., Ohnishi S., Saubermann L.J., Kadowaki T., Blumberg R.S., Nagai R., and Matsuhashi N. Endogenous PPARgamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120 (2001) 460-469
20. Baregamian N., Rychahou P.G., Hawkins H.K., Evers B.M., and Chung D.H. Phosphatidylinositol 3-kinase pathway regulates hypoxia-inducible factor-1 to protect from intestinal injury during necrotizing enterocolitis. Surgery 142 (2007) 295-302
21. Abdelrahman M., Collin M., and Thiemermann C. The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12, 14 prostaglandin J2 reduces the organ injury in hemorrhagic shock. Shock 22 (2004) 555-561
22. Sato N., Kozar R.A., Zou L., Weatherall J.M., Attuwaybi B., Moore-Olufemi S.D., Weisbrodt N.W., and Moore F.A. Peroxisome proliferator-activated receptor gamma mediates protection against cyclooxygenase-2-induced gut dysfunction in a rodent model of mesenteric ischemia/reperfusion. Shock 24 (2005) 462-469
23. Ichikawa H., Naito Y., Takagi T., Tomatsuri N., Yoshida N., and Yoshikawa T. A specific peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand, Pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats. Redox Rep. 7 (2002) 343-346
24. Cuzzocrea S., Di Paola R., Mazzon E., Genovese T., Muia C., and Caputi A.P. WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock. Shock 22 (2004) 340-346
25. Mazzon E., and Cuzzocrea S. Absence of functional peroxisome proliferator-activated receptor-alpha enhanced ileum permeability during experimental colitis. Shock 28 (2007) 192-201
26. Di Paola R., Esposito E., Mazzon E., Genovese T., Muia C., Crisafulli C., Malleo G., Sessa E., Meli R., and Cuzzocrea S. Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan. Shock 26 (2006) 477-484